Has Troy Pittman received payments from drug or device companies?

Yes. Drug and device makers reported $152,917 in general payments to Troy Pittman across 152 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Troy Pittman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Troy Pittman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Troy Pittman

Plastic and Reconstructive Surgery · Washington, DCNPI 1740449271

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $116,128 of the $152,917 with a category attached, or 75.9%. Stryker accounts for 83.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $94,374 and has fallen 91.9% since, to $7,624 in 2025.

$152,917in general payments, 2019–2025

Across 152 payments — averaging $1006.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$127K
Motiva USA, LLC$9K
Sientra, Inc.$7K
Merz North America, Inc.$5K
Surgical Innovation Associates, Inc.$2K
Galderma Laboratories, L.p.$1K
plus $1K from 6 others

What the payments were for

Consulting fees$116,12876%
Travel & lodging$25,87517%
Food & beverage$8,9116%
Gifts$870%
Other$1,9161%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	44	$127,048
Motiva USA, LLC	26	$9,451
Sientra, Inc.	8	$7,256
Merz North America, Inc.	27	$4,622
Surgical Innovation Associates, Inc.	2	$1,916
Galderma Laboratories, L.p.	27	$1,374
AbbVie(2 entities)	11	$784
Integra Lifesciences Corporation	1	$152
Mentor Worldwide LLC	2	$140
Tepha Inc	2	$127
Bard Peripheral Vascular, Inc.	1	$30
Acelrx Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DERMACELL$69,421
SPY TECHNOLOGY$49,753
1588 HD 3 CHIP CAMERA$38,797
SPY-PHI SYSTEM$15,544
1688 HD 3 CHIP CAMERA$13,500
Motiva Implant Matrix$8,938
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$7,065
NEW PRODUCT DEVELOPMENT$2,500
XEOMIN$2,249
DuraSorb Monofilament Mesh$2,068
AIM LAPARASCOPES$2,000
ASCLERA$274
DYSPORT$149
NATRELLE$148
BOTOX$145
NATRELLE SALINE-FILLED BREAST IMPLANTS$143
MENTOR MemoryGel Resterilizable Gel Sizer$135
ALLODERM$120

How this compares

Too few plastic and reconstructive surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other plastic and reconstructive surgery in Washington

David SongWashington$968K
Christopher AttingerWashington$30K
Stephen BakerWashington$8K
Steven DavisonWashington$7K
Daniel TranWashington$3K
Jerry ChaoWashington$3K
Ivica DucicWashington$1K
Paul MartinezWashington$835
Michael BoyajianWashington$577
Steven HoppingWashington$529

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →